AXIC A Stock Overview
A biotechnology company, engages in the development of natural analogue ingredients in Sweden.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
aXichem AB Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | SEK 1.15 |
| 52 Week High | SEK 15.50 |
| 52 Week Low | SEK 0.90 |
| Beta | 0.15 |
| 11 Month Change | -8.37% |
| 3 Month Change | 2.22% |
| 1 Year Change | -85.26% |
| 33 Year Change | -96.03% |
| 5 Year Change | -98.40% |
| Change since IPO | -93.23% |
Recent News & Updates
Shareholder Returns
| AXIC A | SE Chemicals | SE Market | |
|---|---|---|---|
| 7D | -21.5% | -6.5% | -6.7% |
| 1Y | -85.3% | -1.5% | 9.9% |
Return vs Industry: AXIC A underperformed the Swedish Chemicals industry which returned 1.9% over the past year.
Return vs Market: AXIC A underperformed the Swedish Market which returned 12.6% over the past year.
Price Volatility
| AXIC A volatility | |
|---|---|
| AXIC A Average Weekly Movement | 13.9% |
| Chemicals Industry Average Movement | 6.9% |
| Market Average Movement | 5.9% |
| 10% most volatile stocks in SE Market | 12.2% |
| 10% least volatile stocks in SE Market | 3.5% |
Stable Share Price: AXIC A's share price has been volatile over the past 3 months.
Volatility Over Time: AXIC A's weekly volatility has decreased from 21% to 14% over the past year, but is still higher than 75% of Swedish stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 7 | Torsten Helsing | www.axichem.com |
aXichem AB, a biotechnology company, engages in the development of natural analogue ingredients in Sweden. It offers aXivite, a natural analogue capsaicin solution for a range of dietary health applications; aXiphen-bio, a bio-repellent for antifouling protection for vessels and marine installations, pest control in agriculture and forestry, and pest control for cable installations in buildings and underground cables; and aXiphen-feed, a solution for enhanced health for chickens, hens, pigs, and piglets. The company was founded in 1999 and is based in Malmö, Sweden.
aXichem AB Fundamentals Summary
| AXIC A fundamental statistics | |
|---|---|
| Market cap | SEK 67.98m |
| Earnings (TTM) | -SEK 21.36m |
| Revenue (TTM) | SEK 2.06m |
33.0x
P/S Ratio-3.2x
P/E RatioIs AXIC A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| AXIC A income statement (TTM) | |
|---|---|
| Revenue | SEK 2.06m |
| Cost of Revenue | SEK 421.00k |
| Gross Profit | SEK 1.64m |
| Other Expenses | SEK 23.01m |
| Earnings | -SEK 21.36m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.36 |
| Gross Margin | 79.59% |
| Net Profit Margin | -1,035.53% |
| Debt/Equity Ratio | 7.4% |
How did AXIC A perform over the long term?
See historical performance and comparison